Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun;108(4):408-13.
doi: 10.1590/S0074-0276108042013003.

Induction of protective T-helper 1 immune responses against Echinococcus granulosus in mice by a multi-T-cell epitope antigen based on five proteins

Affiliations

Induction of protective T-helper 1 immune responses against Echinococcus granulosus in mice by a multi-T-cell epitope antigen based on five proteins

Majid Esmaelizad et al. Mem Inst Oswaldo Cruz. 2013 Jun.

Abstract

In this study, we designed an experiment to predict a potential immunodominant T-cell epitope and evaluate the protectivity of this antigen in immunised mice. The T-cell epitopes of the candidate proteins (EgGST, EgA31, Eg95, EgTrp and P14-3-3) were detected using available web-based databases. The synthesised DNA was subcloned into the pET41a+ vector and expressed in Escherichia coli as a fusion to glutathione-S-transferase protein (GST). The resulting chimeric protein was then purified by affinity chromatography. Twenty female C57BL/6 mice were immunised with the antigen emulsified in Freund's adjuvant. Mouse splenocytes were then cultured in Dulbecco's Modified Eagle's Medium in the presence of the antigen. The production of interferon-γ was significantly higher in the immunised mice than in the control mice (> 1,300 pg/mL), but interleukin (IL)-10 and IL-4 production was not statistically different between the two groups. In a challenge study in which mice were infected with 500 live protoscolices, a high protectivity level (99.6%) was demonstrated in immunised BALB/C mice compared to the findings in the control groups [GST and adjuvant (Adj)]. These results demonstrate the successful application of the predicted T-cell epitope in designing a vaccine against Echinococcus granulosus in a mouse model.

PubMed Disclaimer

Figures

Fig. 1A
Fig. 1A. western blotting of 81 KDa of chimeric protein by horseradish peroxidase-conjugated anti-glutathione-S-transferase protein (GST) [Lane M: prestained protein molecular weight marker (Vivantis, PR0602); GST-ChMEA: chimeric protein]; B: [Lane M: midrange protein molecular weight marker) Promega, USA); A: supernatant after purification; B: first washing by binding buffer; C: chimeric antigen purified by GST-beads)].
Fig. 2
Fig. 2. production of interferon (IFN)-γ, interleukin (IL)-4 and IL-10 by splenocytes isolated from mice immunised with the chimeric protein, as tested by the sandwich ELISA kit (Quantikine R&D). A: level of IFN-γ; B: level of IL-4; C: level of IL-10; Adj: mice immunised with adjuvant; Cm [glutathione-S-transferase protein (GST)]: cytokine levels in the absence of GST; Cm (GST-ChMEA): cytokine levels in the absence of GST-ChMEA; GST: cytokine levels in the presence of GST in mice immunised with the GST protein; GST-ChMEA: cytokine levels in the presence of the GST-ChMEA in mice immunised with the GST-ChMEA protein. Box plot designed by SPSS 11.5. Asterisk means p < 0.001.
Fig. 3
Fig. 3. immunisation of mice with glutathione-S-transferase protein (GST) induced a significant increase in spleen cell number (A) and in spleen size (B) as well as a slight increase in size of mesenteric lymph nodes (C). C-adjuvant (Adj): injected mice with adjuvant; control-phosphate-buffered saline (PBS): injected mice with phosphate buffer; GST: injected mice with GST protein alone; GST-ChMEA: injected mice with the chimeric protein; *: p < 0.001; **: p < 0.006.

References

    1. Alvarez Rojas CA, Gauci CG, Lightowlers MW. Antigenic differences between the EG95-related proteins from Echinococcus granulosus G1 and G6 genotypes: implications for vaccination. Parasite Immunol. 2013;35:99–102. - PubMed
    1. Billiau A, Matthys P. Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev. 2009;20:97–97. - PubMed
    1. Chow C, Gauci CG, Vural G, Jenkins DJ, Heath DD, Rosenzvit MC, Harandi MF, Lightowlers MW. Echinococcus granulosus: variability of the host-protective EG95 vaccine antigen in G6 and G7 genotypic variants. Exp Parasitol. 2008;119:499–505. - PubMed
    1. Dempster RP, Harrison GBL, Berridge MV. Maternal transfer of protection from Echinococcus granulosus infection in sheep. Res Vet Sci. 1995;58:197–202. - PubMed
    1. Díaz A, Allen JE. Mapping immune response profiles: the emerging scenario from helminth immunology. Eur J Immunol. 2007;37:3319–3326. - PubMed

Publication types